Pål Falck, PhD, MBA

Scientific Advisor
Advisory Board

MBA, PhD in Clinical Nephrology focused Pharmacokinetics. Pål Falck has a broad background within the life science sector including Nordic Medical Director in Oncology & Infections at AstraZeneca, Medical Advisor and Business Development at Pfizer Norway, Healthcare Equity Research Analyst at Arctic Securities in Norway. Pål is the Chief Business Officer at Oncorena AB and a Board Member of University of Oslo, Department of Pharmacy.

Meet More of Our Team
InsuLife is a Norwegian company aiming at bringing the unparalleled developmental Levellor™ spray-based insulin to market.
Learn More
© Copyright 2022 - InsuLife AS, All Rights Reserved